ARCHIVES

Final Issue Of the Year

This article is from The Cancer Letter archive.

Vol. 16 No. 48 | December 14, 1990

Download PDF Visit The Full Archive

Related Articles

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

November 11, 1977

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

SBIR Solicitation Issued

September 13, 1996

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Bioethics Commission Report Calls For funding To Derive Stem Cells

September 17, 1999